Company page

Advagene Biopharma Co., Ltd.

Advagene Biopharma Co., Ltd. is a publicly traded company on the Taiwan stock market under the ticker 6709. The company has a market capitalization of approximately 55.5 million USD. Advagene focuses on biopharmaceutical development, contributing to advancements in healthcare solutions.

profile6709AI content: aiUpdated May 30, 2026/company/advagene-biopharma-co-ltd
Advagene Biopharma Co., Ltd. logo
Ticker
6709
Market cap
$55.5M
Sector
Health Technology
Industry
Biotechnology